(Q36350572)

13 August 2017

1 reference

title

Ensuring the quality, potency and safety of vaccines during preclinical development (English)

1 reference

13 August 2017

Jose A Lebron

1

1 reference

13 August 2017

Jayanthi J Wolf

series ordinal

2

1 reference

13 August 2017

Catherine V Kaplanski

series ordinal

3

1 reference

13 August 2017

Brian J Ledwith

series ordinal

4

1 reference

13 August 2017

language of work or name

1 reference

1 December 2005

1 reference

Expert Review of Vaccines

13 August 2017

published in

1 reference

13 August 2017

volume

4

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

855-866

1 reference

Quality control of biotechnology-derived vaccines: technical and regulatory considerations

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Rapid determination of adenoviral vector titers by quantitative real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Evaluation of meningococcal C oligosaccharide conjugate vaccines by size-exclusion chromatography/multi-angle laser light scattering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

A review of the effectiveness of vaccine potency control testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Peptide mass fingerprinting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Mass spectrometry of whole proteins eluted from sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Quantification of residual host cell DNA in adenoviral vectors produced on PER.C6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.855

21 January 2018

Identifiers

DOI

10.1586/14760584.4.6.855

1 reference

13 August 2017

1 reference